Sublingual immunotherapy is creating a distinct development pathway within the Allergy Immunotherapies Market. FDA-approved sublingual tablets are designed for specific allergens and are administered through the oral route rather than injection. This approach can provide an alternative treatment format for appropriately selected patients. Further formulation development may expand the range of...